Exploration and Application of Intelligent Difficult Airway Assessment Scheme
1 other identifier
observational
475
1 country
1
Brief Summary
The study aims to explore the effectiveness of an intelligent difficult airway assessment protocol and its potential in clinical applications. The management of difficult airways is a critical task in anesthesiology, and poor management can lead to severe complications or even death. The American Society of Anesthesiologists defines a difficult airway as one that presents difficulties in mask ventilation or endotracheal intubation. Previous studies have shown that the incidence of difficult airways is not low in patients undergoing general anesthesia, emphasizing the need for optimization of airway management strategies. Preoperative airway assessment is an essential step in preventing complications associated with difficult airways. Currently, the modified Mallampati classification and the Cormack-Lehane grading are two commonly used assessment tools. However, these methods rely on the subjective judgment of clinicians and may have limitations in accuracy and consistency. With the development of artificial intelligence and telemedicine technologies, new assessment methods have become possible, offering more precise measurements and analysis of airway anatomy. This study proposes an intelligent airway assessment system that combines phonation modulation and tongue position adjustment, aiming to improve the accuracy and reliability of assessments. The system uses deep learning algorithms to analyze oral images of subjects to predict airway difficulty. The study will also explore the correlation of this system with traditional assessment methods and establish a predictive model for difficult airways. As a country with a large population, China has a significant demand for medical and health resources, especially in the fields of surgery and anesthesia. The diversity of China's population may affect airway structure, thereby influencing airway management strategies. Therefore, conducting such research in China has important clinical significance and social value.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 23, 2024
CompletedFirst Submitted
Initial submission to the registry
October 2, 2024
CompletedFirst Posted
Study publicly available on registry
October 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2025
CompletedFebruary 18, 2026
February 1, 2026
4 months
October 2, 2024
February 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between intelligent airway assessment and modification of Mallampati classification and Cormack-Lehane grading.
From enrollment to one day after extubation.
Eligibility Criteria
Patients scheduled for elective general anesthesia with endotracheal intubation.
You may qualify if:
- Age ≥18 years, with no gender restrictions;
- Subjects who are scheduled to undergo elective general anesthesia and require endotracheal intubation;
- Subjects classified as American Society of Anesthesiologists Physical Status (ASA-PS) Class I, II, and III;
- Volunteers who are willing to participate in this clinical trial and have signed the Informed Consent Form.
You may not qualify if:
- Subjects with known airway deformities, tumors, or other structural abnormalities that may affect airway assessment;
- Subjects with psychiatric disorders or other conditions that prevent cooperation;
- Pregnant or lactating women;
- Subjects who have participated in other interventional clinical trials within 1 month prior to the start of this trial;
- Subjects deemed inappropriate to participate in this clinical trial by the investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Min Sulead
Study Sites (1)
First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Biospecimen
Modified Mallampati classification, Cormack-Lehane grading, thyromental distance, interincisal distance, and cervical mobility involved with the patient.
Study Officials
- STUDY DIRECTOR
Min Su
First Affiliated Hospital of Chongqing Medical University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 2, 2024
First Posted
October 3, 2024
Study Start
September 23, 2024
Primary Completion
January 10, 2025
Study Completion
January 10, 2025
Last Updated
February 18, 2026
Record last verified: 2026-02